Latest Thrombosis Stories

2012-03-02 13:09:46

Researchers from the University of North Carolina at Chapel Hill reduced damage from a heart attack by 50 percent by enhancing a protective protein found in mice and humans. The study, in which mice were bred to make a supercharged version of the protein focal adhesion kinase, or FAK, appeared March 1 in the online edition of the journal Arteriosclerosis, Thrombosis and Vascular Biology. "This study shows that we can enhance existing cell survival pathways to protect heart cells during a...

2012-03-02 11:25:28

Scientists modified a protein in the heart which dramatically reduced cell damage after heart attacks, according to new research published the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology. The modified protein reduced cell damage by 50 percent in mice without causing harmful inflammation, the researchers found. Those results came during research looking at ways to prevent heart failure induced by heart attack. The protein is called focal adhesion...

2012-02-23 08:00:00

According to court documents, on February 15th, 2012, North Dakota resident Donna L. Praus filed a lawsuit (case no. 3:2012cv20009) in the Illinois Southern District Court against Bayer Pharmaceuticals, the company manufacturing Yasmin, claiming that she suffered an alleged deep vein thrombosis (DVT) from taking Yasmin and its similar sister Yaz. Yasmin is a birth control pill that has been on the market since 2001. Last month, as reported by the Washington monthly and BMJ, an advisory...

2012-02-21 06:04:39

(Ivanhoe Newswire)-- Patients who are receiving chemotherapy for cancer are at risk for venous thromboembolism.  Now, researchers show how a new treatment may help. In a double blind study the effectiveness and safety of ultra-low-molecular-weight heparin semuloparin was tested in the prevention of venous thromboembolism in patients with metastatic or locally advanced solid tumors who are just starting to receive chemotherapy. The results showed that venous thromboemeolism occurred...

2012-02-16 11:17:48

For decades, the blood thinner heparin has been used to prevent and treat blood clots. Could it be just as effective in treating cancer? In an editorial published today in the New England Journal of Medicine, researchers from McMaster University and the University at Buffalo suggest conclusive answers to key questions on the benefits of low molecular weight heparin (LMWH) for cancer patients remain elusive - despite promising results from large studies. Co-authors of the editorial are...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'